These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8719365)

  • 1. Does anamnestic symptom evaluation or clinical examination give enough information to evaluate the severity of obstruction in benign prostatic hyperplasia?
    Waldén M; Geirsson G; Pettersson S; Schäfer W; Dahlstrand C
    Scand J Urol Nephrol; 1995 Dec; 29(4):469-76. PubMed ID: 8719365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision of a patient-weighted symptom score in prostatism. The DAN-PSS-1 questionnaire.
    Brasso K; Stigsby B; Pilsgård B; Nordling J
    Scand J Urol Nephrol; 1994 Mar; 28(1):71-5. PubMed ID: 7516575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of detrusor instability and symptoms with objective parameters used for diagnosing bladder outlet obstruction: a prospective study.
    Wadie BS; Ebrahim el-HE; Gomha MA
    J Urol; 2002 Jul; 168(1):132-4. PubMed ID: 12050506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of resistive index, detrusor wall thickness and ultrasound estimated bladder weight regarding the outcome after transurethral prostatectomy for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Huang T; Qi J; Yu YJ; Xu D; Jiao Y; Kang J; Chen YQ; Zhu YK
    Int J Urol; 2012 Apr; 19(4):343-50. PubMed ID: 22220830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of symptom score, quality of life score, maximal urinary flow rate, residual volume and prostate size for the diagnosis of obstructive benign prostatic hyperplasia: a urodynamic analysis.
    van Venrooij GE; Boon TA
    J Urol; 1996 Jun; 155(6):2014-8. PubMed ID: 8618311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction.
    Rosario DJ; Woo H; Potts KL; Cutinha PE; Hastie KJ; Chapple CR
    Br J Urol; 1997 Oct; 80(4):579-86. PubMed ID: 9352697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: analysis of subjective changes, morbidity and mortality.
    van Melick HH; van Venrooij GE; Eckhardt MD; Boon TA
    J Urol; 2003 Apr; 169(4):1411-6. PubMed ID: 12629374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations of urodynamic changes with changes in symptoms and well-being after transurethral resection of the prostate.
    Van Venrooij GE; Van Melick HH; Eckhardt MD; Boon TA
    J Urol; 2002 Aug; 168(2):605-9. PubMed ID: 12131318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia.
    Cowles RS; Kabalin JN; Childs S; Lepor H; Dixon C; Stein B; Zabbo A
    Urology; 1995 Aug; 46(2):155-60. PubMed ID: 7542818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
    Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals.
    Gerber GS; Jahoda A; Bales GT; Albala DM
    Tech Urol; 1997; 3(1):25-9. PubMed ID: 9170221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the diagnostic criteria of bladder outlet obstruction in benign prostatic hyperplasia].
    Shuang W; Wang D; Zhang X; Liu C; Cao X; Wang J; Gao J; Ren Z; Lü Y
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):743-6. PubMed ID: 15562786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up after transurethral resection of the prostate, contact laser prostatectomy, and electrovaporization.
    van Melick HH; van Venrooij GE; Boon TA
    Urology; 2003 Dec; 62(6):1029-34. PubMed ID: 14665349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid laser treatment compared with transurethral resection of the prostate for symptomatic bladder outlet obstruction caused by a large benign prostate: a prospective, randomized trial with a 6-month follow-up.
    Tuhkanen K; Heino A; Alaopas M
    BJU Int; 1999 Nov; 84(7):805-9. PubMed ID: 10532976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up?
    Rigatti L; Naspro R; Salonia A; Centemero A; Ghezzi M; Guazzoni G; Briganti A; Rigatti P; Montorsi F
    Urology; 2006 Jun; 67(6):1193-8. PubMed ID: 16750253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual laser ablation of the prostate: efficacy evaluated by urodynamics and compared to TURP.
    Jung P; Mattelaer P; Wolff JM; Mersdorf A; Jakse G
    Eur Urol; 1996; 30(4):418-23. PubMed ID: 8977061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.